The eye is the window to patient health.
Optain’s non-invasive clinical support tools harness the power of AI-enabled algorithms to analyse full-colour retinal images to screen for referable diseases and evaluate patient's health.
We look into the future and see a better quality of life.
Our future health depends on
Location: United States, New York, New City
Employees: 1-10
Total raised: $12M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.05.2023 | Seed | $12M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 09.05.2023 | Optain Launches with $12M in Seed Funding | Optain, a New York-based AI company that uses photos of the eye to detect and prevent early stage di... | finsmes.co... |
| 09.05.2023 | Using AI for eye disease detection, Optain launches with $12... | Optain is the first company to come out of Ascertain from Northwell Health and Aegis Ventures In Apr... | vator.tv/n... |
| - | Optain | “Optain” | fastfounde... |